Pharma & Healthcare
Global Drugs of Bioengineered Protein Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4154
- Pages: 106
- Figures: 137
- Views: 51
Bioengineered proteins are synthesized using genetic engineering. They are also called as recombinant protein. Bioengineered protein drugs are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.
Market Analysis and Insights: Global Drugs of Bioengineered Protein Market
The global Drugs of Bioengineered Protein market is projected to grow from US$ 3526 million in 2024 to US$ 5001.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Drugs of Bioengineered Protein market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs of Bioengineered Protein, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs of Bioengineered Protein, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs of Bioengineered Protein revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs of Bioengineered Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs of Bioengineered Protein revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Sanofi
Eli Lilly
Roche
Dr. Reddy's Laboratories
Abbott Laboratories
Amgen
Bayer AG
Biocon
Fresenius kabi
Panacea Biotec
Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segment by Application
Endocrinology
Immunology
Hematology
Infectiology
Neurology
Oncology
Genetic Disorder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drugs of Bioengineered Protein in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs of Bioengineered Protein companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs of Bioengineered Protein revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Drugs of Bioengineered Protein Market
The global Drugs of Bioengineered Protein market is projected to grow from US$ 3526 million in 2024 to US$ 5001.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Drugs of Bioengineered Protein market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs of Bioengineered Protein, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs of Bioengineered Protein, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs of Bioengineered Protein revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs of Bioengineered Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs of Bioengineered Protein revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Sanofi
Eli Lilly
Roche
Dr. Reddy's Laboratories
Abbott Laboratories
Amgen
Bayer AG
Biocon
Fresenius kabi
Panacea Biotec
Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segment by Application
Endocrinology
Immunology
Hematology
Infectiology
Neurology
Oncology
Genetic Disorder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drugs of Bioengineered Protein in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs of Bioengineered Protein companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs of Bioengineered Protein revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Market by Application
1.3.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Endocrinology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Infectiology
1.3.6 Neurology
1.3.7 Oncology
1.3.8 Genetic Disorder
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs of Bioengineered Protein Market Perspective (2019-2030)
2.2 Global Drugs of Bioengineered Protein Growth Trends by Region
2.2.1 Drugs of Bioengineered Protein Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs of Bioengineered Protein Historic Market Size by Region (2019-2024)
2.2.3 Drugs of Bioengineered Protein Forecasted Market Size by Region (2025-2030)
2.3 Drugs of Bioengineered Protein Market Dynamics
2.3.1 Drugs of Bioengineered Protein Industry Trends
2.3.2 Drugs of Bioengineered Protein Market Drivers
2.3.3 Drugs of Bioengineered Protein Market Challenges
2.3.4 Drugs of Bioengineered Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs of Bioengineered Protein by Players
3.1.1 Global Drugs of Bioengineered Protein Revenue by Players (2019-2024)
3.1.2 Global Drugs of Bioengineered Protein Revenue Market Share by Players (2019-2024)
3.2 Global Drugs of Bioengineered Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs of Bioengineered Protein, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Drugs of Bioengineered Protein Market Concentration Ratio
3.4.1 Global Drugs of Bioengineered Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs of Bioengineered Protein Revenue in 2023
3.5 Global Key Players of Drugs of Bioengineered Protein Head office and Area Served
3.6 Global Key Players of Drugs of Bioengineered Protein, Product and Application
3.7 Global Key Players of Drugs of Bioengineered Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs of Bioengineered Protein Breakdown Data by Type
4.1 Global Drugs of Bioengineered Protein Historic Market Size by Type (2019-2024)
4.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2025-2030)
5 Drugs of Bioengineered Protein Breakdown Data by Application
5.1 Global Drugs of Bioengineered Protein Historic Market Size by Application (2019-2024)
5.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs of Bioengineered Protein Market Size (2019-2030)
6.2 North America Drugs of Bioengineered Protein Market Size by Type
6.2.1 North America Drugs of Bioengineered Protein Market Size by Type (2019-2024)
6.2.2 North America Drugs of Bioengineered Protein Market Size by Type (2025-2030)
6.2.3 North America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
6.3 North America Drugs of Bioengineered Protein Market Size by Application
6.3.1 North America Drugs of Bioengineered Protein Market Size by Application (2019-2024)
6.3.2 North America Drugs of Bioengineered Protein Market Size by Application (2025-2030)
6.3.3 North America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
6.4 North America Drugs of Bioengineered Protein Market Size by Country
6.4.1 North America Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Drugs of Bioengineered Protein Market Size by Country (2019-2024)
6.4.3 North America Drugs of Bioengineered Protein Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs of Bioengineered Protein Market Size (2019-2030)
7.2 Europe Drugs of Bioengineered Protein Market Size by Type
7.2.1 Europe Drugs of Bioengineered Protein Market Size by Type (2019-2024)
7.2.2 Europe Drugs of Bioengineered Protein Market Size by Type (2025-2030)
7.2.3 Europe Drugs of Bioengineered Protein Market Share by Type (2019-2030)
7.3 Europe Drugs of Bioengineered Protein Market Size by Application
7.3.1 Europe Drugs of Bioengineered Protein Market Size by Application (2019-2024)
7.3.2 Europe Drugs of Bioengineered Protein Market Size by Application (2025-2030)
7.3.3 Europe Drugs of Bioengineered Protein Market Share by Application (2019-2030)
7.4 Europe Drugs of Bioengineered Protein Market Size by Country
7.4.1 Europe Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Drugs of Bioengineered Protein Market Size by Country (2019-2024)
7.4.3 Europe Drugs of Bioengineered Protein Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs of Bioengineered Protein Market Size (2019-2030)
8.2 China Drugs of Bioengineered Protein Market Size by Type
8.2.1 China Drugs of Bioengineered Protein Market Size by Type (2019-2024)
8.2.2 China Drugs of Bioengineered Protein Market Size by Type (2025-2030)
8.2.3 China Drugs of Bioengineered Protein Market Share by Type (2019-2030)
8.3 China Drugs of Bioengineered Protein Market Size by Application
8.3.1 China Drugs of Bioengineered Protein Market Size by Application (2019-2024)
8.3.2 China Drugs of Bioengineered Protein Market Size by Application (2025-2030)
8.3.3 China Drugs of Bioengineered Protein Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drugs of Bioengineered Protein Market Size (2019-2030)
9.2 Asia Drugs of Bioengineered Protein Market Size by Type
9.2.1 Asia Drugs of Bioengineered Protein Market Size by Type (2019-2024)
9.2.2 Asia Drugs of Bioengineered Protein Market Size by Type (2025-2030)
9.2.3 Asia Drugs of Bioengineered Protein Market Share by Type (2019-2030)
9.3 Asia Drugs of Bioengineered Protein Market Size by Application
9.3.1 Asia Drugs of Bioengineered Protein Market Size by Application (2019-2024)
9.3.2 Asia Drugs of Bioengineered Protein Market Size by Application (2025-2030)
9.3.3 Asia Drugs of Bioengineered Protein Market Share by Application (2019-2030)
9.4 Asia Drugs of Bioengineered Protein Market Size by Region
9.4.1 Asia Drugs of Bioengineered Protein Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Drugs of Bioengineered Protein Market Size by Region (2019-2024)
9.4.3 Asia Drugs of Bioengineered Protein Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Introduction
11.1.4 GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs of Bioengineered Protein Introduction
11.2.4 Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Drugs of Bioengineered Protein Introduction
11.3.4 Merck Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drugs of Bioengineered Protein Introduction
11.4.4 Novartis Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.4.5 Novartis Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drugs of Bioengineered Protein Introduction
11.5.4 Sanofi Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.5.5 Sanofi Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Drugs of Bioengineered Protein Introduction
11.6.4 Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.6.5 Eli Lilly Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Drugs of Bioengineered Protein Introduction
11.7.4 Roche Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.8.5 Dr. Reddy's Laboratories Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Introduction
11.9.4 Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.9.5 Abbott Laboratories Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Drugs of Bioengineered Protein Introduction
11.10.4 Amgen Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.10.5 Amgen Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Drugs of Bioengineered Protein Introduction
11.11.4 Bayer AG Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.11.5 Bayer AG Recent Developments
11.12 Biocon
11.12.1 Biocon Company Details
11.12.2 Biocon Business Overview
11.12.3 Biocon Drugs of Bioengineered Protein Introduction
11.12.4 Biocon Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.12.5 Biocon Recent Developments
11.13 Fresenius kabi
11.13.1 Fresenius kabi Company Details
11.13.2 Fresenius kabi Business Overview
11.13.3 Fresenius kabi Drugs of Bioengineered Protein Introduction
11.13.4 Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.13.5 Fresenius kabi Recent Developments
11.14 Panacea Biotec
11.14.1 Panacea Biotec Company Details
11.14.2 Panacea Biotec Business Overview
11.14.3 Panacea Biotec Drugs of Bioengineered Protein Introduction
11.14.4 Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.14.5 Panacea Biotec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Market by Application
1.3.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Endocrinology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Infectiology
1.3.6 Neurology
1.3.7 Oncology
1.3.8 Genetic Disorder
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs of Bioengineered Protein Market Perspective (2019-2030)
2.2 Global Drugs of Bioengineered Protein Growth Trends by Region
2.2.1 Drugs of Bioengineered Protein Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs of Bioengineered Protein Historic Market Size by Region (2019-2024)
2.2.3 Drugs of Bioengineered Protein Forecasted Market Size by Region (2025-2030)
2.3 Drugs of Bioengineered Protein Market Dynamics
2.3.1 Drugs of Bioengineered Protein Industry Trends
2.3.2 Drugs of Bioengineered Protein Market Drivers
2.3.3 Drugs of Bioengineered Protein Market Challenges
2.3.4 Drugs of Bioengineered Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs of Bioengineered Protein by Players
3.1.1 Global Drugs of Bioengineered Protein Revenue by Players (2019-2024)
3.1.2 Global Drugs of Bioengineered Protein Revenue Market Share by Players (2019-2024)
3.2 Global Drugs of Bioengineered Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs of Bioengineered Protein, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Drugs of Bioengineered Protein Market Concentration Ratio
3.4.1 Global Drugs of Bioengineered Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs of Bioengineered Protein Revenue in 2023
3.5 Global Key Players of Drugs of Bioengineered Protein Head office and Area Served
3.6 Global Key Players of Drugs of Bioengineered Protein, Product and Application
3.7 Global Key Players of Drugs of Bioengineered Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs of Bioengineered Protein Breakdown Data by Type
4.1 Global Drugs of Bioengineered Protein Historic Market Size by Type (2019-2024)
4.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2025-2030)
5 Drugs of Bioengineered Protein Breakdown Data by Application
5.1 Global Drugs of Bioengineered Protein Historic Market Size by Application (2019-2024)
5.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs of Bioengineered Protein Market Size (2019-2030)
6.2 North America Drugs of Bioengineered Protein Market Size by Type
6.2.1 North America Drugs of Bioengineered Protein Market Size by Type (2019-2024)
6.2.2 North America Drugs of Bioengineered Protein Market Size by Type (2025-2030)
6.2.3 North America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
6.3 North America Drugs of Bioengineered Protein Market Size by Application
6.3.1 North America Drugs of Bioengineered Protein Market Size by Application (2019-2024)
6.3.2 North America Drugs of Bioengineered Protein Market Size by Application (2025-2030)
6.3.3 North America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
6.4 North America Drugs of Bioengineered Protein Market Size by Country
6.4.1 North America Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Drugs of Bioengineered Protein Market Size by Country (2019-2024)
6.4.3 North America Drugs of Bioengineered Protein Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs of Bioengineered Protein Market Size (2019-2030)
7.2 Europe Drugs of Bioengineered Protein Market Size by Type
7.2.1 Europe Drugs of Bioengineered Protein Market Size by Type (2019-2024)
7.2.2 Europe Drugs of Bioengineered Protein Market Size by Type (2025-2030)
7.2.3 Europe Drugs of Bioengineered Protein Market Share by Type (2019-2030)
7.3 Europe Drugs of Bioengineered Protein Market Size by Application
7.3.1 Europe Drugs of Bioengineered Protein Market Size by Application (2019-2024)
7.3.2 Europe Drugs of Bioengineered Protein Market Size by Application (2025-2030)
7.3.3 Europe Drugs of Bioengineered Protein Market Share by Application (2019-2030)
7.4 Europe Drugs of Bioengineered Protein Market Size by Country
7.4.1 Europe Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Drugs of Bioengineered Protein Market Size by Country (2019-2024)
7.4.3 Europe Drugs of Bioengineered Protein Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs of Bioengineered Protein Market Size (2019-2030)
8.2 China Drugs of Bioengineered Protein Market Size by Type
8.2.1 China Drugs of Bioengineered Protein Market Size by Type (2019-2024)
8.2.2 China Drugs of Bioengineered Protein Market Size by Type (2025-2030)
8.2.3 China Drugs of Bioengineered Protein Market Share by Type (2019-2030)
8.3 China Drugs of Bioengineered Protein Market Size by Application
8.3.1 China Drugs of Bioengineered Protein Market Size by Application (2019-2024)
8.3.2 China Drugs of Bioengineered Protein Market Size by Application (2025-2030)
8.3.3 China Drugs of Bioengineered Protein Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drugs of Bioengineered Protein Market Size (2019-2030)
9.2 Asia Drugs of Bioengineered Protein Market Size by Type
9.2.1 Asia Drugs of Bioengineered Protein Market Size by Type (2019-2024)
9.2.2 Asia Drugs of Bioengineered Protein Market Size by Type (2025-2030)
9.2.3 Asia Drugs of Bioengineered Protein Market Share by Type (2019-2030)
9.3 Asia Drugs of Bioengineered Protein Market Size by Application
9.3.1 Asia Drugs of Bioengineered Protein Market Size by Application (2019-2024)
9.3.2 Asia Drugs of Bioengineered Protein Market Size by Application (2025-2030)
9.3.3 Asia Drugs of Bioengineered Protein Market Share by Application (2019-2030)
9.4 Asia Drugs of Bioengineered Protein Market Size by Region
9.4.1 Asia Drugs of Bioengineered Protein Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Drugs of Bioengineered Protein Market Size by Region (2019-2024)
9.4.3 Asia Drugs of Bioengineered Protein Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Introduction
11.1.4 GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs of Bioengineered Protein Introduction
11.2.4 Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Drugs of Bioengineered Protein Introduction
11.3.4 Merck Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drugs of Bioengineered Protein Introduction
11.4.4 Novartis Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.4.5 Novartis Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drugs of Bioengineered Protein Introduction
11.5.4 Sanofi Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.5.5 Sanofi Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Drugs of Bioengineered Protein Introduction
11.6.4 Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.6.5 Eli Lilly Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Drugs of Bioengineered Protein Introduction
11.7.4 Roche Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.8.5 Dr. Reddy's Laboratories Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Introduction
11.9.4 Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.9.5 Abbott Laboratories Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Drugs of Bioengineered Protein Introduction
11.10.4 Amgen Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.10.5 Amgen Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Drugs of Bioengineered Protein Introduction
11.11.4 Bayer AG Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.11.5 Bayer AG Recent Developments
11.12 Biocon
11.12.1 Biocon Company Details
11.12.2 Biocon Business Overview
11.12.3 Biocon Drugs of Bioengineered Protein Introduction
11.12.4 Biocon Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.12.5 Biocon Recent Developments
11.13 Fresenius kabi
11.13.1 Fresenius kabi Company Details
11.13.2 Fresenius kabi Business Overview
11.13.3 Fresenius kabi Drugs of Bioengineered Protein Introduction
11.13.4 Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.13.5 Fresenius kabi Recent Developments
11.14 Panacea Biotec
11.14.1 Panacea Biotec Company Details
11.14.2 Panacea Biotec Business Overview
11.14.3 Panacea Biotec Drugs of Bioengineered Protein Introduction
11.14.4 Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2019-2024)
11.14.5 Panacea Biotec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Therapeutic Proteins
Table 4. Key Players of Vaccines
Table 5. Global Drugs of Bioengineered Protein Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Drugs of Bioengineered Protein Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drugs of Bioengineered Protein Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Drugs of Bioengineered Protein Market Share by Region (2019-2024)
Table 9. Global Drugs of Bioengineered Protein Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Drugs of Bioengineered Protein Market Share by Region (2025-2030)
Table 11. Drugs of Bioengineered Protein Market Trends
Table 12. Drugs of Bioengineered Protein Market Drivers
Table 13. Drugs of Bioengineered Protein Market Challenges
Table 14. Drugs of Bioengineered Protein Market Restraints
Table 15. Global Drugs of Bioengineered Protein Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Drugs of Bioengineered Protein Revenue Share by Players (2019-2024)
Table 17. Global Top Drugs of Bioengineered Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2023)
Table 18. Global Drugs of Bioengineered Protein Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Drugs of Bioengineered Protein Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Drugs of Bioengineered Protein, Headquarters and Area Served
Table 21. Global Key Players of Drugs of Bioengineered Protein, Product and Application
Table 22. Global Key Players of Drugs of Bioengineered Protein, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2019-2024)
Table 26. Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2025-2030)
Table 28. Global Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Drugs of Bioengineered Protein Revenue Share by Application (2019-2024)
Table 30. Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Drugs of Bioengineered Protein Revenue Share by Application (2025-2030)
Table 32. North America Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Drugs of Bioengineered Protein Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Drugs of Bioengineered Protein Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Drugs of Bioengineered Protein Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Drugs of Bioengineered Protein Product
Table 67. GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Drugs of Bioengineered Protein Product
Table 72. Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Developments
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Drugs of Bioengineered Protein Product
Table 77. Merck Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Drugs of Bioengineered Protein Product
Table 82. Novartis Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Drugs of Bioengineered Protein Product
Table 87. Sanofi Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 88. Sanofi Recent Developments
Table 89. Eli Lilly Company Details
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Drugs of Bioengineered Protein Product
Table 92. Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly Recent Developments
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Drugs of Bioengineered Protein Product
Table 97. Roche Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 98. Roche Recent Developments
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Developments
Table 104. Abbott Laboratories Company Details
Table 105. Abbott Laboratories Business Overview
Table 106. Abbott Laboratories Drugs of Bioengineered Protein Product
Table 107. Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 108. Abbott Laboratories Recent Developments
Table 109. Amgen Company Details
Table 110. Amgen Business Overview
Table 111. Amgen Drugs of Bioengineered Protein Product
Table 112. Amgen Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 113. Amgen Recent Developments
Table 114. Bayer AG Company Details
Table 115. Bayer AG Business Overview
Table 116. Bayer AG Drugs of Bioengineered Protein Product
Table 117. Bayer AG Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 118. Bayer AG Recent Developments
Table 119. Biocon Company Details
Table 120. Biocon Business Overview
Table 121. Biocon Drugs of Bioengineered Protein Product
Table 122. Biocon Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 123. Biocon Recent Developments
Table 124. Fresenius kabi Company Details
Table 125. Fresenius kabi Business Overview
Table 126. Fresenius kabi Drugs of Bioengineered Protein Product
Table 127. Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 128. Fresenius kabi Recent Developments
Table 129. Panacea Biotec Company Details
Table 130. Panacea Biotec Business Overview
Table 131. Panacea Biotec Drugs of Bioengineered Protein Product
Table 132. Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 133. Panacea Biotec Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Drugs of Bioengineered Protein Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Therapeutic Proteins Features
Figure 5. Vaccines Features
Figure 6. Global Drugs of Bioengineered Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Drugs of Bioengineered Protein Market Share by Application: 2023 VS 2030
Figure 8. Endocrinology Case Studies
Figure 9. Immunology Case Studies
Figure 10. Hematology Case Studies
Figure 11. Infectiology Case Studies
Figure 12. Neurology Case Studies
Figure 13. Oncology Case Studies
Figure 14. Genetic Disorder Case Studies
Figure 15. Drugs of Bioengineered Protein Report Years Considered
Figure 16. Global Drugs of Bioengineered Protein Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Drugs of Bioengineered Protein Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Drugs of Bioengineered Protein Market Share by Region: 2023 VS 2030
Figure 19. Global Drugs of Bioengineered Protein Market Share by Players in 2023
Figure 20. Global Top Drugs of Bioengineered Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2023
Figure 22. North America Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 24. North America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 25. North America Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 26. United States Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 29. Europe Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 30. Europe Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 31. Europe Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 32. Germany Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 39. China Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 40. China Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 41. Asia Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 42. Asia Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 43. Asia Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 44. Asia Drugs of Bioengineered Protein Market Share by Region (2019-2030)
Figure 45. Japan Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 55. Brazil Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 62. Johnson & Johnson Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 64. Novartis Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 65. Sanofi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 66. Eli Lilly Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 67. Roche Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 69. Abbott Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 70. Amgen Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 71. Bayer AG Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 72. Biocon Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 73. Fresenius kabi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 74. Panacea Biotec Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Table 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Therapeutic Proteins
Table 4. Key Players of Vaccines
Table 5. Global Drugs of Bioengineered Protein Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Drugs of Bioengineered Protein Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drugs of Bioengineered Protein Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Drugs of Bioengineered Protein Market Share by Region (2019-2024)
Table 9. Global Drugs of Bioengineered Protein Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Drugs of Bioengineered Protein Market Share by Region (2025-2030)
Table 11. Drugs of Bioengineered Protein Market Trends
Table 12. Drugs of Bioengineered Protein Market Drivers
Table 13. Drugs of Bioengineered Protein Market Challenges
Table 14. Drugs of Bioengineered Protein Market Restraints
Table 15. Global Drugs of Bioengineered Protein Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Drugs of Bioengineered Protein Revenue Share by Players (2019-2024)
Table 17. Global Top Drugs of Bioengineered Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2023)
Table 18. Global Drugs of Bioengineered Protein Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Drugs of Bioengineered Protein Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Drugs of Bioengineered Protein, Headquarters and Area Served
Table 21. Global Key Players of Drugs of Bioengineered Protein, Product and Application
Table 22. Global Key Players of Drugs of Bioengineered Protein, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2019-2024)
Table 26. Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2025-2030)
Table 28. Global Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Drugs of Bioengineered Protein Revenue Share by Application (2019-2024)
Table 30. Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Drugs of Bioengineered Protein Revenue Share by Application (2025-2030)
Table 32. North America Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Drugs of Bioengineered Protein Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Drugs of Bioengineered Protein Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Drugs of Bioengineered Protein Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size by Country (2025-2030) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Drugs of Bioengineered Protein Product
Table 67. GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Drugs of Bioengineered Protein Product
Table 72. Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Developments
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Drugs of Bioengineered Protein Product
Table 77. Merck Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Drugs of Bioengineered Protein Product
Table 82. Novartis Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Drugs of Bioengineered Protein Product
Table 87. Sanofi Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 88. Sanofi Recent Developments
Table 89. Eli Lilly Company Details
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Drugs of Bioengineered Protein Product
Table 92. Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly Recent Developments
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Drugs of Bioengineered Protein Product
Table 97. Roche Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 98. Roche Recent Developments
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Developments
Table 104. Abbott Laboratories Company Details
Table 105. Abbott Laboratories Business Overview
Table 106. Abbott Laboratories Drugs of Bioengineered Protein Product
Table 107. Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 108. Abbott Laboratories Recent Developments
Table 109. Amgen Company Details
Table 110. Amgen Business Overview
Table 111. Amgen Drugs of Bioengineered Protein Product
Table 112. Amgen Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 113. Amgen Recent Developments
Table 114. Bayer AG Company Details
Table 115. Bayer AG Business Overview
Table 116. Bayer AG Drugs of Bioengineered Protein Product
Table 117. Bayer AG Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 118. Bayer AG Recent Developments
Table 119. Biocon Company Details
Table 120. Biocon Business Overview
Table 121. Biocon Drugs of Bioengineered Protein Product
Table 122. Biocon Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 123. Biocon Recent Developments
Table 124. Fresenius kabi Company Details
Table 125. Fresenius kabi Business Overview
Table 126. Fresenius kabi Drugs of Bioengineered Protein Product
Table 127. Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 128. Fresenius kabi Recent Developments
Table 129. Panacea Biotec Company Details
Table 130. Panacea Biotec Business Overview
Table 131. Panacea Biotec Drugs of Bioengineered Protein Product
Table 132. Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2019-2024) & (US$ Million)
Table 133. Panacea Biotec Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Drugs of Bioengineered Protein Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Therapeutic Proteins Features
Figure 5. Vaccines Features
Figure 6. Global Drugs of Bioengineered Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Drugs of Bioengineered Protein Market Share by Application: 2023 VS 2030
Figure 8. Endocrinology Case Studies
Figure 9. Immunology Case Studies
Figure 10. Hematology Case Studies
Figure 11. Infectiology Case Studies
Figure 12. Neurology Case Studies
Figure 13. Oncology Case Studies
Figure 14. Genetic Disorder Case Studies
Figure 15. Drugs of Bioengineered Protein Report Years Considered
Figure 16. Global Drugs of Bioengineered Protein Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Drugs of Bioengineered Protein Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Drugs of Bioengineered Protein Market Share by Region: 2023 VS 2030
Figure 19. Global Drugs of Bioengineered Protein Market Share by Players in 2023
Figure 20. Global Top Drugs of Bioengineered Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2023
Figure 22. North America Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 24. North America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 25. North America Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 26. United States Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 29. Europe Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 30. Europe Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 31. Europe Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 32. Germany Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 39. China Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 40. China Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 41. Asia Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 42. Asia Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 43. Asia Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 44. Asia Drugs of Bioengineered Protein Market Share by Region (2019-2030)
Figure 45. Japan Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Size YoY (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Drugs of Bioengineered Protein Market Share by Country (2019-2030)
Figure 55. Brazil Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Drugs of Bioengineered Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 62. Johnson & Johnson Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 64. Novartis Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 65. Sanofi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 66. Eli Lilly Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 67. Roche Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 69. Abbott Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 70. Amgen Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 71. Bayer AG Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 72. Biocon Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 73. Fresenius kabi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 74. Panacea Biotec Revenue Growth Rate in Drugs of Bioengineered Protein Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232